Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAP4K1 | Q92918 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | QPCT | Q16769 | 1/20 | 0.36 |
| ▸ | MPO | P05164 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6871051 | 1.00 | NOTUM (0.44) | NOTUMMAOANAAAGAAG6PD | |
| SCHEMBL8585033 | 1.00 | NOTUM (0.44) | NOTUMMAOANAAAGAAG6PD | |
| SCHEMBL29348773 | 0.82 | MEN1 (0.40) | NOTUML3MBTL1ALDH1A1MAPTHPGD | |
| SCHEMBL29348772 | 0.82 | MEN1 (0.40) | NOTUML3MBTL1ALDH1A1MAPTHPGD | |
| SCHEMBL29348775 | 0.82 | MEN1 (0.40) | NOTUML3MBTL1ALDH1A1MAPTHPGD | |
| SCHEMBL2365942 | 0.82 | USP2 (0.46) | NAAAL3MBTL1SMN1; SMN2USP2ALDH1A1 | |
| SCHEMBL2365947 | 0.82 | USP2 (0.46) | NAAAL3MBTL1SMN1; SMN2USP2ALDH1A1 | |
| SCHEMBL22771222 | 0.80 | CYP11B2 (0.47) | GAAL3MBTL1ALDH1A1MAPTIDH1 | |
| SCHEMBL1937070 | 0.80 | MAP4K1 (0.43) | MAP4K1ALDH1A1MAPTGRM2MEN1 | |
| SCHEMBL4458253 | 0.78 | PDE3B (0.41) | NOTUMMAOANAAAMAP4K1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210379574-A1 | MULTI-FUNCTIONALIZED HOLLOW FIBER ORGANOCATALYSTS | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2021-12-09 | — | — | US | disclosed |
| EP-2858983-A1 | TNF -ALPHA MODULATING BENZIMIDAZOLES | UCB Biopharma SPRL (BE) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013186229-A1 | TNF -ALPHA MODULATING BENZIMIDAZOLES | UCB PHARMA S.A. (BE) | 2013-12-19 | — | — | WO | disclosed |
| US-20040081682-A1 | Transdermal system (tds) that contain inhibitors of phosphodiesterase lV | NEUROBIOTEC GMBH (DE) | 2004-04-29 | — | — | US | disclosed |
| EP-1343484-A2 | TRANSDERMAL SYSTEMS (TDS) THAT CONTAIN INHIBITORS OF PHOSPHODIESTERASE IV | Günther, Clemens (DE) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002049606-A2 | TRANSDERMAL SYSTEMS (TDS) THAT CONTAIN INHIBITORS OF PHOSPHODIESTERASE IV | GUENTHER CLEMENS (DE) | 2002-06-27 | — | — | WO | disclosed |
| CN-1077103-C | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 2002-01-02 | — | — | CN | disclosed |
| CN-1077103-C | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 2002-01-02 | — | — | CN | disclosed |
| CN-1077103-C | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 2002-01-02 | — | — | CN | disclosed |
| EP-0859766-B1 | CHIRAL METHYL PHENYL OXAZOLIDINONES | SCHERING AG (DE) | 2001-05-16 | — | — | EP | disclosed |
| US-6025376-A | INHIBITORS OF TUMOR NECROSIS FACTOR, TREATING MULTIPLE SCLEROSIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-02-15 | — | — | US | disclosed |
| CN-1200115-A | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 1998-11-25 | — | — | CN | disclosed |
| CN-1200115-A | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 1998-11-25 | — | — | CN | disclosed |
| CN-1200115-A | Chiral methyl phenyl oxazolidinones | SCHERING AG (DE) | 1998-11-25 | — | — | CN | disclosed |
| EP-0859766-A1 | CHIRAL METHYL PHENYL OXAZOLIDINONES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-08-26 | — | — | EP | disclosed |
| EP-0859766-A1 | CHIRAL METHYL PHENYL OXAZOLIDINONES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-08-26 | — | — | EP | disclosed |
| WO-1997015561-A1 | CHIRAL METHYL PHENYL OXAZOLIDINONES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997015561-A1 | CHIRAL METHYL PHENYL OXAZOLIDINONES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-05-01 | — | — | WO | disclosed |
| EP-0632802-A1 | NEW ALKYLATING REAGENT, PROCESS FOR PREPARING THE SAME AND ITS USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-01-11 | — | — | EP | disclosed |
| WO-1993019043-A1 | NEW ALKYLATING REAGENT, PROCESS FOR PREPARING THE SAME AND ITS USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040081682-A1 | Transdermal system (tds) that contain inhibitors of phosphodiesterase lV | PDE12, PDE3B, PDE5A | NOTUM 479/4885MAOA 63/4885NAAA 2882/4885 |
| US-20210379574-A1 | MULTI-FUNCTIONALIZED HOLLOW FIBER ORGANOCATALYSTS | HAAO, DCAF1, HPD | NOTUM 487/4885MAOA 1223/4885NAAA 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.